Goldwin Health Care Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 02-07-2024
- Paid Up Capital ₹ 1.00 M
as on 02-07-2024
- Company Age 17 Year, 6 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 13.73 Cr
as on 02-07-2024
- Revenue -4.17%
(FY 2023)
- Profit -397.94%
(FY 2023)
- Ebitda -138.17%
(FY 2023)
- Net Worth -13.32%
(FY 2023)
- Total Assets -11.31%
(FY 2023)
About Goldwin Health Care
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹13.73 Cr.
Kirit Jadav and Dinesh Thakkar serve as directors at the Company.
- CIN/LLPIN
U85100MH2008PTC177781
- Company No.
177781
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jan 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Goldwin Health Care Private Limited offer?
Goldwin Health Care Private Limited offers a wide range of products and services, including Paper Rolls, Thermal Paper Rolls, Paper & Paper Made Products, Juices, Soups & Soft Drinks, Beverages Mixes, Paper Billing Roll, Kraft Paper.
Who are the key members and board of directors at Goldwin Health Care?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kirit Jadav  | Director | 04-May-2022 | Current |
| Dinesh Thakkar | Director | 30-Mar-2023 | Current |
Financial Performance of Goldwin Health Care.
Goldwin Health Care Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.17% decrease. The company also saw a substantial fall in profitability, with a 397.94% decrease in profit. The company's net worth observed a substantial decline by a decrease of 13.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Goldwin Health Care?
In 2023, Goldwin Health Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 11 Sep 2023 | ₹2.50 Cr | Open |
Others Creation Date: 17 Jul 2023 | ₹1.55 Cr | Open |
Others Creation Date: 30 Jun 2023 | ₹7.00 Cr | Open |
How Many Employees Work at Goldwin Health Care?
Goldwin Health Care has a workforce of 14 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Goldwin Health Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Goldwin Health Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
